Vahdati-Mashhadian Nasser, Hassanzadeh Mohammad K, Hosseini Javad, Saffareshargh Ali A
School of Pharmacy, Drug Research Center, Mashhad University of Medical Sciences, Iran.
Can J Physiol Pharmacol. 2004 May;82(5):326-30. doi: 10.1139/y04-030.
One thousand Iranians belonging to 5 different Iranian ethnic groups were tested for butyrylcholinesterase (BChE) activity and phenotype. The phenotype was measured as percent inhibition in the presence of dibucaine. It was found that the Iranian population had an extraordinarily high frequency of the atypical variant of butyrylcholinesterase. 70% to 80% of Iranians carried the atypical mutation (Asp70Gly) on one allele. This contrasts with European and American populations where only 4% carry the atypical allele. The atypical variant of butyrylcholinesterase is known to be associated with prolonged apnea after administration of the muscle relaxants succinylcholine and mivacurium, and is also thought to be associated with abnormal sensitivity to cocaine toxicity. This study demonstrates that the ethnic background of a person has an important role in a person's response to drugs.
对属于5个不同伊朗族群的1000名伊朗人进行了丁酰胆碱酯酶(BChE)活性和表型检测。表型通过在存在丁卡因的情况下的抑制百分比来衡量。研究发现,伊朗人群中丁酰胆碱酯酶非典型变体的频率异常高。70%至80%的伊朗人在一个等位基因上携带非典型突变(Asp70Gly)。这与欧美人群形成对比,在欧美人群中只有4%携带非典型等位基因。已知丁酰胆碱酯酶的非典型变体与使用肌肉松弛剂琥珀酰胆碱和米库氯铵后呼吸暂停延长有关,也被认为与对可卡因毒性的异常敏感性有关。这项研究表明,人的种族背景在其对药物的反应中起着重要作用。